首页 | 本学科首页   官方微博 | 高级检索  
     

前列腺癌内分泌治疗患者血清睾酮浓度变化与进展为CRPC关系的研究
引用本文:刘任功,张赫岩,范晋铭,黄文军,张羽. 前列腺癌内分泌治疗患者血清睾酮浓度变化与进展为CRPC关系的研究[J]. 中国卫生标准管理, 2021, 0(3): 68-71
作者姓名:刘任功  张赫岩  范晋铭  黄文军  张羽
作者单位:齐齐哈尔市第一医院泌尿外科
基金项目:齐齐哈尔市科技计划创新激励项目(名称:前列腺癌内分泌治疗患者血清睾酮浓度变化与进展为CRPC关系的研究;编号:CSFGG-2020067)。
摘    要:目的 旨在研究局部进展期前列腺癌诊疗过程中睾酮水平变化的临床指导意义.方法 回顾性选取2015年1月—2018年1月间我院泌尿外科住院治疗的36例局部进展期前列腺癌患者,根据患者治疗以来睾酮水平最高点将患者分为低浓度组、中浓度组和高浓度组.对患者进行随访,记录患者的进展时间,比较各组患者去势抵抗型前列腺癌比例、进展时间...

关 键 词:前列腺癌  阻断治疗  睾酮  进展时间  总生存期  内分泌治疗

Study on the Relationship Between the Testosterone Concentration Changes in Endocrine Therapy of Prostate Cancer and Developing Into Castration-resistant Prostate Cancer
LIU Rengong,ZHANG Heyan,FAN Jinming,HUANG Wenjun,ZHANG Yu. Study on the Relationship Between the Testosterone Concentration Changes in Endocrine Therapy of Prostate Cancer and Developing Into Castration-resistant Prostate Cancer[J]. China Health Standard Management, 2021, 0(3): 68-71
Authors:LIU Rengong  ZHANG Heyan  FAN Jinming  HUANG Wenjun  ZHANG Yu
Affiliation:(Department of Urology,Qiqihar First Hospital,Qiqihar Heilongjiang 161000,China)
Abstract:Objective To study the clinical guiding significance of testosterone levels during the diagnosis and treatment of locally advanced prostate cancer.Methods 36 patients with locally advanced prostate cancer who were hospitalized in our hospital from January 2015 to January 2018 were selected.According to the highest point of testosterone since the treatment,the patients were divided into low-concentration group and medium-concentration group and high concentration groups.Followed up the patients,recorded the progress time of the patients,compared the proportion,progress time and overall survival of patients with castrationresistant prostate cancer in each group,and analyzed the correlation of testosterone level with the progress time and overall survival.Results The proportion of castration-resistant prostate cancer in the low-concentration group,medium-concentration group,and high-concentration group increased sequentially,and the progression time and overall survival period were successively shortened.The differences were statistically significant(P<0.05);testosterone levels were the same as the progression time and the overall survival period was significantly positively correlated(P<0.05).Conclusion There is a certain relationship between testosterone level in patients with castration-resistant prostate cancer and treatment effect and prognosis.
Keywords:prostate cancer  blocking therapy  testosterone  time to progression  overall survival  endocrine therapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号